GlassScriptPhysician profile
Seetharaman Ashok
NPI 1669408415
$9,675.12
in general payments reported to CMS, 2019-2025
25 companies · $1,139 in 2025
The $1,139 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,593 · 2020: $387 · 2021: $444 · 2022: $2,653 · 2023: $300 · 2024: $2,158 · 2025: $1,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,221 · Food and Beverage: $1,270 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,220.86 |
| Food and Beverage | $1,270.30 |
| Education | $106.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,639.55 | 2019-2025 | Ams 700 |
| Procept Biorobotics Corporation | $1,169.28 | 2024 | Aquabeam System |
| Teleflex LLC | $823.69 | 2024 | Urolift |
| Astellas Pharma US INC | $739.62 | 2019-2025 | Xtandi |
| Olympus Corporation of The Americas | $702.08 | 2025 | Itind System |
| Dentsply Ih INC. | $629.46 | 2019 | |
| Intuitive Surgical, INC. | $256.68 | 2020 | |
| Janssen Biotech, INC. | $217.93 | 2022-2025 | Erleada |
| Neotract INC. | $214.14 | 2019 | |
| Olympus America INC. | $155.55 | 2022-2025 | Itind System |
| Medtronic, INC. | $146.02 | 2021 | |
| Abbvie INC. | $131.87 | 2019 | |
| Coloplast Corp | $124.79 | 2020-2022 | |
| Antares Pharma, INC. | $123.62 | 2023 | Xyosted |
| Sumitomo Pharma America, INC. | $100.68 | 2023 | Orgovyx |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $95.36 | 2020-2022 | |
| Pfizer INC. | $70.73 | 2019-2023 | |
| Accord Healthcare, INC. | $70.12 | 2024 | |
| Urogen Pharma, INC. | $67.64 | 2020-2024 | |
| Dendreon Pharmaceuticals LLC | $56.18 | 2019-2025 | Provenge |
| Verity Pharmaceuticals INC. | $45.46 | 2023-2024 | Trelstar |
| Srs Medical Systems, INC. | $30.41 | 2021-2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Axonics, INC. | $24.52 | 2023 | Axonics |
| Karl Storz Endoscopy-America | $23.76 | 2024 | Hopkins |
| Myovant Sciences INC. | $15.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seetharaman Ashok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.